Page last updated: 2024-09-03

iodofiltic acid and Kidney Diseases

iodofiltic acid has been researched along with Kidney Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inoue, T; Ishigami, T; Ishikawa, T; Kimura, K; Sugano, T; Takahashi, N; Takamura, T; Uchino, K; Umemura, S1
Iwamoto, N; Kikuchi, K; Nishimura, M; Ono, T; Tamaki, N; Tsukamoto, K1

Other Studies

2 other study(ies) available for iodofiltic acid and Kidney Diseases

ArticleYear
Combining chronic kidney disease with 201thallium/123iodine beta methyliodophenyl pentadecanoic acid dual myocardial single-photon emission computed tomography findings is useful for the evaluation of cardiac event risk.
    Nuclear medicine communications, 2009, Volume: 30, Issue:1

    Topics: Aged; Chronic Disease; Fatty Acids; Female; Follow-Up Studies; Glomerular Filtration Rate; Heart; Heart Diseases; Humans; Iodobenzenes; Kaplan-Meier Estimate; Kidney Diseases; Male; Multivariate Analysis; Myocardium; Prognosis; Risk; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Treatment Outcome

2009
Risk stratification for cardiac death in hemodialysis patients without obstructive coronary artery disease.
    Kidney international, 2011, Volume: 79, Issue:3

    Topics: Aged; Cause of Death; Chi-Square Distribution; Chronic Disease; Coronary Angiography; Coronary Circulation; Disease-Free Survival; Fatty Acids; Female; Heart Diseases; Humans; Insulin Resistance; Iodobenzenes; Japan; Kaplan-Meier Estimate; Kidney Diseases; Male; Middle Aged; Myocardial Perfusion Imaging; Myocardium; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Renal Dialysis; Risk Assessment; Risk Factors; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome

2011